Jacquelyn J. Cragg

3.0k total citations · 1 hit paper
79 papers, 2.0k citations indexed

About

Jacquelyn J. Cragg is a scholar working on Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health and Surgery. According to data from OpenAlex, Jacquelyn J. Cragg has authored 79 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pathology and Forensic Medicine, 20 papers in Public Health, Environmental and Occupational Health and 14 papers in Surgery. Recurrent topics in Jacquelyn J. Cragg's work include Spinal Cord Injury Research (35 papers), Nerve Injury and Rehabilitation (9 papers) and Cerebral Palsy and Movement Disorders (7 papers). Jacquelyn J. Cragg is often cited by papers focused on Spinal Cord Injury Research (35 papers), Nerve Injury and Rehabilitation (9 papers) and Cerebral Palsy and Movement Disorders (7 papers). Jacquelyn J. Cragg collaborates with scholars based in Canada, United States and Switzerland. Jacquelyn J. Cragg's co-authors include Andrei V. Krassioukov, Jaimie Borisoff, Vanessa K. Noonan, Catherine R. Jutzeler, Armin Curt, Lisa Kuramoto, Raúl de la Fuente‐Fernández, Vesna Sossi, Michael Schulzer and A. Jon Stoessl and has published in prestigious journals such as Science, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Jacquelyn J. Cragg

71 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cell-based and stem-cell-based treatments for spinal cord injury: evidence from clinical trials

2022 190 citations Jacquelyn J. Cragg, James D. Guest et al. profile →

Peers

Countries citing papers authored by Jacquelyn J. Cragg

Since Specialization

Citations

This map shows the geographic impact of Jacquelyn J. Cragg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacquelyn J. Cragg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacquelyn J. Cragg more than expected).

Fields of papers citing papers by Jacquelyn J. Cragg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacquelyn J. Cragg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacquelyn J. Cragg. The network helps show where Jacquelyn J. Cragg may publish in the future.

Co-authorship network of co-authors of Jacquelyn J. Cragg

This figure shows the co-authorship network connecting the top 25 collaborators of Jacquelyn J. Cragg. A scholar is included among the top collaborators of Jacquelyn J. Cragg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacquelyn J. Cragg. Jacquelyn J. Cragg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Scoping review of biosimilar disease-modifying antirheumatic drugs in pregnancy: evidence gaps and proposed outcome reporting framework 2025 ·Rheumatology International ·(unknown), Neda Amiri, (unknown), Ursula Ellis, Jacquelyn J. Cragg, Laurie Proulx, (unknown), Mary A. De Vera	0
2	Pregnancy Outcomes of Targeted Synthetic Disease‐Modifying Antirheumatic Drugs Among Patients With Autoimmune Diseases: A Scoping Review 2025 ·Arthritis Care & Research ·(unknown), Neda Amiri, (unknown), Ursula Ellis, Jacquelyn J. Cragg, Mark Harrison, Laurie Proulx, Mary A. De Vera	3
3	Pregnancy outcomes of non-tumour necrosis factor inhibitor biologic disease-modifying antirheumatic drugs among individuals with autoimmune diseases: a scoping review and proposed framework for reporting outcomes 2025 ·(unknown), Neda Amiri, (unknown), Ursula Ellis, Jacquelyn J. Cragg, Laurie Proulx, Mary A. De Vera	1
4	A cross-sectional study investigating age of multiple sclerosis onset and its association with self-management knowledge and behaviors 2025 ·Multiple Sclerosis and Related Disorders ·(unknown), Brian M. Feldman, Brenda Banwell, Joseph Beyene, Jacquelyn J. Cragg, Amit Bar-Or, Marcia Finlayson, Melanie Guenette, Larry D. Lynd, (unknown), Alène Toulany, Anthony Traboulsee, E. Ann Yeh, Jiwon Oh	0
5	“What’s Sex and Gender Got to Do With It?” A Scoping Review of Sex- and Gender-Based Analysis in Pharmacoepidemiologic Studies of Medication Adherence 2023 ·Value in Health ·(unknown), Michael R. Law, Jacquelyn J. Cragg, Lori A. Brotto, Ursula Ellis, (unknown), (unknown), Mary A. De Vera	10
6	Pharmacological management of acute spinal cord injury: a longitudinal multi-cohort observational study 2023 ·Scientific Reports ·Catherine R. Jutzeler, Lucie Bourguignon, Bobo Tong, (unknown), (unknown), Noam Y. Harel, Fred H. Geisler, Adam R. Ferguson, Brian K. Kwon, Jacquelyn J. Cragg, Lukas Grassner, John L. K. Kramer	10
7	Perspectives on Data Sharing in Persons With Spinal Cord Injury 2023 ·SHILAP Revista de lepidopterología ·(unknown), Bobo Tong, (unknown), Kathleen A. Martin Ginis, Alexander G. Rabchevsky, Jacquelyn J. Cragg, John L. K. Kramer	2
8	Amphetamine-related care in the USA, 2003–2014: cross-sectional analyses examining inpatient trends and factors associated with hospitalisation outcomes 2022 ·BMJ Open ·(unknown), James A. G. Crispo, Paxton Bach, Dominique R. Ansell, Dylan Thibault, Allison W. Willis, Jacquelyn J. Cragg	1
9	A national survey of physical activity after spinal cord injury 2022 ·Scientific Reports ·(unknown), Jordan W. Squair, Jacquelyn J. Cragg, Jennifer Thompson, (unknown), Bita Vaseghi, Carolyn A. Emery, Christopher J. Grant, Rebecca Charbonneau, (unknown), Aaron A. Phillips, Željko Dujić	19
10	16-year trends in asthma hospital admissions in Canada 2022 ·Annals of Allergy Asthma & Immunology ·(unknown), John Petkau, (unknown), Abdollah Safari, Jacquelyn J. Cragg, Larry D. Lynd, J. Mark FitzGerald, Stuart E. Turvey, Mohsen Sadatsafavi	7
11	A systematic, concept‐based method of developing the exposure measure for drug safety and effectiveness studies 2021 ·Pharmacoepidemiology and Drug Safety ·Lisa Kuramoto, Boris Sobolev, Jan Rösner, Penelope M. A. Brasher, Laurent Azoulay, Jacquelyn J. Cragg	3
12	A Systematic Review of Safety Reporting in Acute Spinal Cord Injury Clinical Trials: Challenges and Recommendations 2021 ·Journal of Neurotrauma ·(unknown), (unknown), (unknown), Jacquelyn J. Cragg, Adam R. Ferguson, James D. Guest, Jane Hsieh, Linda Jones, Steven Kirshblum, Daniel P. Lammertse, Brian K. Kwon, John L. K. Kramer	3
13	Beneficial “Pharmaceutical Pleiotropy” of Gabapentinoids in Spinal Cord Injury: A Case for Refining Standard-of-Care 2020 ·Neurorehabilitation and neural repair ·Jacquelyn J. Cragg, Catherine R. Jutzeler, Lukas Grassner, Matt S. Ramer, Frank Bradke, John L. K. Kramer	4
14	Constructing treatment episodes from concomitant medication logs: a prospective observational study 2020 ·BMJ Open ·Lisa Kuramoto, Boris Sobolev, Penelope M. A. Brasher, (unknown), Jacquelyn J. Cragg	3
15	The Effect of Non-Gabapentinoid Anticonvulsants on Sensorimotor Recovery After Human Spinal Cord Injury 2019 ·CNS Drugs ·(unknown), Catherine R. Jutzeler, Jacquelyn J. Cragg, Bobo Tong, Lukas Grassner, Frank Bradke, Fred H. Geisler, John K. G. Kramer	12
16	Prevalence of chronic pain among individuals with neurological conditions. 2018 ·PubMed ·Jacquelyn J. Cragg, (unknown), Matthew Shupler, Catherine R. Jutzeler, Neil R. Cashman, David G. T. Whitehurst, (unknown)	17
17	Ecological fallacy as a novel risk factor for poor translation in neuroscience research: A systematic review and simulation study 2018 ·European Journal of Clinical Investigation ·Jacquelyn J. Cragg, John L. K. Kramer, Jaimie Borisoff, David M. Patrick, Matt S. Ramer	5
18	Placebo response in neuropathic pain after spinal cord injury: a meta-analysis of individual participant data 2018 ·Journal of Pain Research ·Catherine R. Jutzeler, (unknown), Jacquelyn J. Cragg, Jenny Haefeli, Scott Richards, (unknown), Nanna Brix Finnerup, Catherine Mercier, John K. G. Kramer	8
19	National Survey of Bladder and Gastrointestinal Dysfunction in People with Spinal Cord Injury 2018 ·Journal of Neurotrauma ·Jordan W. Squair, (unknown), Jacquelyn J. Cragg, Rebecca Charbonneau, Christopher J. Grant, Aaron A. Phillips	7
20	Extent of spontaneous motor recovery after traumatic cervical sensorimotor complete spinal cord injury 2010 ·Spinal Cord ·(unknown), John D. Steeves, J. K. G. Kramer, James W. Fawcett, Jacquelyn J. Cragg, Daniel P. Lammertse, Andrew R. Blight, Ralph J. Marino, John F. Ditunno, W P Coleman, Fred H. Geisler, James D. Guest, Linda Jones, Stephen F. Burns, Martin Schubert, Hubertus J. A. van Hedel, Armin Curt	132

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact